Guardant Health, Inc. (GH)

Guardant Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	12,238	13,160	3,775	3,283	2,786	10,168
Market Cap Growth	105.84%	248.64%	14.96%	17.84%	-72.60%	-21.09%
Enterprise Value	12,747	13,906	4,187	3,487	3,045	9,850
Last Close Price	93.30	102.14	30.55	27.05	27.20	100.02
PS Ratio	12.46	13.40	5.11	5.82	6.20	27.21
PB Ratio	-	-132.51	-27.03	20.69	46.30	15.76
P/TBV Ratio	-	-	-	22.43	61.69	16.20
EV/Sales Ratio	12.98	14.16	5.67	6.18	6.77	26.36
Debt / Equity Ratio	-17.22	-17.22	-9.57	8.53	22.75	2.13
Net Debt / Equity Ratio	-5.12	-5.12	-3.55	1.17	5.95	-0.40
Net Debt / EBITDA Ratio	-1.28	-1.28	-1.24	-0.42	-0.70	0.66
Net Debt / FCF Ratio	-2.18	-2.18	-1.80	-0.54	-0.92	0.91
Asset Turnover	0.56	0.56	0.45	0.33	0.24	0.17
Inventory Turnover	4.45	4.45	4.36	4.00	3.80	4.60
Quick Ratio	4.43	4.43	4.21	6.11	5.74	5.29
Current Ratio	4.84	4.84	4.68	6.54	6.17	5.72
Return on Equity (ROE)	-	-	-4584.47%	-438.12%	-185.65%	-38.46%
Return on Assets (ROA)	-15.58%	-15.58%	-16.91%	-17.71%	-17.84%	-11.48%
Return on Capital Employed (ROCE)	-25.50%	-25.50%	-35.10%	-30.40%	-38.40%	-20.40%
Earnings Yield	-3.40%	-3.16%	-11.56%	-14.60%	-23.49%	-3.99%
FCF Yield	-1.90%	-1.77%	-7.28%	-10.52%	-13.89%	-2.79%
Buyback Yield / Dilution	-2.14%	-2.14%	-9.61%	-9.60%	-0.85%	-3.91%

Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q